ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,808Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 24

$2.08M Total Retail Price of All Prescriptions

Rank: 1 out of 24

742 Patients Receiving at Least One Drug in Part D
19%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 742 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

6% of this provider’s 2,730 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$140 was the average price of a prescription from this provider, compared to $130 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
ABILIFY 755 93 1 4
RISPERIDONE 637 136 2 1
TRAZODONE HCL 631 74 3 3
BUPROPION XL 565 86 4 13
CITALOPRAM HBR 550 150 5 6
QUETIAPINE FUMARATE 543 53 6 5
FLUOXETINE HCL 527 121 7 9
VENLAFAXINE HCL ER 499 78 8 11
CLOZAPINE 482 53 9 2
MIRTAZAPINE 463 137 10 10
LAMOTRIGINE 402 55 11 8
ZOLPIDEM TARTRATE 386 74 12 19
SERTRALINE HCL 385 80 13 7
BENZTROPINE MESYLATE 379 80 R 14 15
CYMBALTA 374 89 15 14
TOPIRAMATE 370 25 16 20
OLANZAPINE 293 124 17 12
LITHIUM CARBONATE 275 38 18 17
BUPROPION HCL SR 257 91 19 23
AMPHETAMINE SALT COMBO 246 31 S2 20 28
SEROQUEL 236 32 21 21
DIVALPROEX SODIUM 231 62 22 18
DIVALPROEX SODIUM ER 219 28 23 22
ZIPRASIDONE HCL 209 20 24 25
ESCITALOPRAM OXALATE 207 54 25 16
PAROXETINE HCL 200 49 26 24
PRAZOSIN HCL 142 0 27 48
CARBAMAZEPINE 121 11 28 32
HYDROXYZINE PAMOATE 111 0 R 29 33
LATUDA 111 12 29 35
OMEPRAZOLE 110 19 31 37
LEXAPRO 104 33 32 36
DONEPEZIL HCL 103 62 33 31
PROPRANOLOL HCL 101 25 34 39
NAMENDA 97 46 35 26
GABAPENTIN 95 0 36 29
THIORIDAZINE HCL 89 43 R 37 56
HALOPERIDOL 89 17 37 56
GEODON 87 15 39 47
DOXEPIN HCL 82 39 40 59
METHYLPHENIDATE HCL 79 16 41 41
INVEGA SUSTENNA 78 0 42 34
TRIHEXYPHENIDYL HCL 78 17 R 42 61
ZYPREXA 72 17 44 45
DEXTROAMPHETAMINE-AMPHETAMINE 70 0 S2 45 64
SAPHRIS 69 0 46 65
VIIBRYD 62 0 47 68
HYDROXYZINE HCL 61 0 R 48 50
SEROQUEL XR 59 0 49 30
INVEGA 57 0 50 49
LOXAPINE 56 0 51 71
LEVOTHYROXINE SODIUM 53 0 52 38
CLONIDINE HCL 53 0 52 52
PERPHENAZINE 53 14 52 76
BUSPIRONE HCL 52 0 55 27
PRAMIPEXOLE DIHYDROCHLORIDE 51 24 56 78
BUPROPION HCL 50 0 57 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.